Cargando…
Angiopoietin-like 3 inhibition and the liver: less is more?
PURPOSE OF REVIEW: The aim of this study was to discuss the potential mechanisms and implications of the opposing liver safety results from recent angiopoietin-like 3 (ANGPTL3) inhibition studies. RECENT FINDINGS: The clinical development of vupanorsen, a N-acetylgalactosamine (GalNAc) antisense tar...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10624415/ https://www.ncbi.nlm.nih.gov/pubmed/37820081 http://dx.doi.org/10.1097/MOL.0000000000000898 |